A Bmi1-miRNAs Cross-Talk Modulates Chemotherapy Response to 5-Fluorouracil in Breast Cancer Cells

Jiang Yin, Guopei Zheng, Xiaoting Jia, Zhijie Zhang, Weijia Zhang, Ying Song, Yan Xiong, Zhimin HePLoS 2013 · DOI · OpenAlex

Abstract

Chemotherapy resistance remains a significant hurdle in breast cancer treatment, often driven by the persistence of cancer stem cells (CSCs). This study investigates the role of the polycomb group protein Bmi1 in mediating resistance to 5-Fluorouracil (5-Fu). We found that Bmi1 is significantly upregulated in 5-Fu-resistant and aggressive breast cancer cell lines. This overexpression correlates with an enrichment of the CD44+/CD24- CSC subpopulation. Mechanistically, Bmi1 expression is directly repressed by miR-200c and miR-203. Conversely, Bmi1 suppresses miR-200c expression through a p53-dependent pathway, creating a regulatory feedback loop. Knockdown of Bmi1 resensitizes resistant cells to 5-Fu by inducing mitochondrial apoptosis and reducing the CSC fraction, highlighting Bmi1 as a potential therapeutic target.

Introduction

The primary cause of treatment failure and disease relapse in breast cancer is the development of resistance to chemotherapeutic agents like 5-Fluorouracil (5-Fu). Emerging evidence suggests that a small population of cells, termed Cancer Stem Cells (CSCs), possesses intrinsic resistance mechanisms and the capacity for self-renewal. Bmi1, a key regulator of stem cell maintenance, has been implicated in various cancers, yet its specific contribution to breast cancer chemoresistance and its regulatory network involving microRNAs (miRNAs) required further elucidation.

Methods

The researchers employed several breast cancer cell models, including the sensitive MCF-7 line, its lab-derived 5-Fu resistant counterpart (MCF-7/5-Fu), and naturally aggressive lines (MDA-MB-231 and MDA-MB-453). To manipulate gene expression, shRNA was used for Bmi1 knockdown, while expression plasmids and synthetic miRNA mimics were used for overexpression. The physical interaction between miRNAs and the Bmi1 3’UTR was confirmed via luciferase reporter assays. Cellular phenotypes were assessed through flow cytometry (for CSC markers and apoptosis) and MTS assays to determine cell viability and IC50 values.

Results

Bmi1 Upregulation and Chemoresistance

Initial experiments revealed a strong correlation between Bmi1 levels and resistance to 5-Fu. Bmi1 protein and mRNA levels were markedly higher in the resistant MCF-7/5-Fu line and the aggressive MDA-MB-231 and MDA-MB-453 lines compared to the parental MCF-7 cells.

Bmi1 expression is significantly higher in 5-Fu resistant and aggressive breast cancer cell lines compared to sensitive MCF-7 cells.

Functional Impact of Bmi1 on Cell Survival

To confirm Bmi1's role in resistance, the researchers modulated its expression. Overexpressing Bmi1 in sensitive MCF-7 cells increased their survival index when exposed to 5-Fu. Conversely, silencing Bmi1 in resistant cells (MCF-7/5-Fu/Sh) significantly enhanced their sensitivity to the drug, as evidenced by the downward shift in survival curves.

Survival index curves demonstrating that Bmi1 knockdown (Sh) sensitizes resistant cells to 5-Fu, while Bmi1 overexpression increases resistance in sensitive cells.

The miRNA-Bmi1-p53 Regulatory Loop

The study identified miR-200c and miR-203 as direct negative regulators of Bmi1. Luciferase assays showed that these miRNAs bind to the Bmi1 3’UTR, reducing its expression. Interestingly, a reciprocal relationship was discovered: Bmi1 suppresses miR-200c. This suppression is mediated by p53; Bmi1 downregulates p53, which is a known transcriptional activator of miR-200c. Restoring p53 expression was sufficient to reverse Bmi1-mediated miR-200c downregulation.

Discussion

This research maps a complex molecular cross-talk where Bmi1 promotes 5-Fu resistance by maintaining the CSC population and inhibiting apoptosis through the mitochondrial pathway. The discovery of the Bmi1-miRNA-p53 feedback loop provides a clearer picture of how cancer cells sustain high Bmi1 levels to evade treatment. While these in vitro findings are promising, further in vivo studies are necessary to validate Bmi1 inhibition as a viable clinical strategy. Targeting this regulatory axis could potentially overcome drug resistance and improve outcomes for breast cancer patients.

Summary updated

Abstract

The polycomb group transcriptional modifier Bmi1 is often upregulated in numerous cancers and is intensely involved in normal and cancer stem cells, and importantly is as a prognostic indicator for some cancers, but its role in breast cancer remains unclear. Here, we found Bmi1 overexpression in 5-Fu (5-fluorouracil)-resistant MCF-7 cells (MCF-7/5-Fu) derived from MCF-7 breast cancer cells, MDA-MB-231 and MDA-MB-453 breast cancer cells compared to MCF-7 cells, was related with 5-Fu resistance and enrichment of CD44(+)/CD24(-) stem cell subpopulation. Bmi1 knockdown enhanced the sensitivity of breast cancer cells to 5-Fu and 5-Fu induced apoptosis via mitochondrial apoptotic pathway, and decreased the fraction of CD44(+)/CD24(-) subpopulation. In addition, our analysis showed inverse expression pattern between Bmi1 and miR-200c and miR-203 in selected breast cancer cell lines, and miR-200c and miR-203 directly repressed Bmi1 expression in protein level confirmed by luciferase reporter assay. MiR-200c and miR-203 overexpression in breast cancer cells downregulated Bmi1 expression accompanied with reversion of resistance to 5-Fu mediated by Bmi1. Inversely, Bmi1 overexpression inhibited miR-200c expression in MCF-7 cells, but not miR-203, however ectopic wild-type p53 expression reversed Bmi1 mediated miR-200c downregulation, suggesting the repressive effect of Bmi1 on miR-200c maybe depend on p53. Thus, our study suggests a cross-talk between Bmi1 and miR-200c mediated by p53, and Bmi1 interference would improve chemotherapy efficiency in breast cancer via susceptive apoptosis induction and cancer stem cell enrichment inhibition.
BibTeX
@inproceedings{yin2013bmi,
  author = {Jiang Yin and Guopei Zheng and Xiaoting Jia and Zhijie Zhang and Weijia Zhang and Ying Song and Yan Xiong and Zhimin He},
  title = {{A Bmi1-miRNAs Cross-Talk Modulates Chemotherapy Response to 5-Fluorouracil in Breast Cancer Cells}},
  booktitle = {PLoS},
  year = {2013},
  doi = {10.1371/journal.pone.0073268},
}
Figure